CD1530
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-108527-5MG | 5 mg | 153,00 | Add | |
| HY-108527-10MG | 10 mg | 267,00 | Add | |
| HY-108527-25MG | 25 mg | 584,00 | Add | |
| HY-108527-50MG | 50 mg | 1'040,00 | Add | |
| HY-108527-100MG | 100 mg | 1'914,00 | Add | |
| HY-108527-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
CD1530 is a selective RARγ agonist with an Kd of 150 nM[1]. CD1530 has been used in combination with bexarotene to inhibit oral carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide in a mouse model of human oral-cavity and esophageal squamous-cell carcinoma[2].
| Category | Protein |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, Metabolic Enzyme/Protease,Vitamin D Related/Nuclear Receptor |
| Format | Solubility: DMSO : 100 mg/mL (ultrasonic) |
| Grade | Clinical information: No Development Reported |
| Purity | 98.13% |
| Molecular Formula | C27H26O3 |
| Molecular Weight | 398.49 |
| CAS-Number | 107430-66-0 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
